Chronic obstructive pulmonary disease and drugs of ingredients of bicalutamide (a real world drug study)
Summary:
Chronic obstructive pulmonary disease is found among people who take drugs with ingredients of bicalutamide, especially for people who are male, 60+ old , have been taking the drugs for < 1 month. This phase IV clinical study is created by eHealthMe based on reports of 20,239 people who have side effects when taking drugs with ingredients of bicalutamide from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Bicalutamide, Casodex.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
20,239 people reported to have side effects when taking drugs with ingredients of bicalutamide.
Among them, 227 people (1.12%) have Chronic obstructive pulmonary disease
What is Chronic obstructive pulmonary disease?
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe) is found to be associated with 1,803 drugs and 2,209 conditions by eHealthMe. Check the latest studies of Chronic obstructive pulmonary disease.
Number of reports submitted per year:
Time on drugs with ingredients of bicalutamide when people have Chronic obstructive pulmonary disease *:
- < 1 month: 76.92 %
- 1 - 6 months: 23.08 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Chronic obstructive pulmonary disease when taking drugs with ingredients of bicalutamide *:
- female: 5.26 %
- male: 94.74 %
Age of people who have Chronic obstructive pulmonary disease when taking drugs with ingredients of bicalutamide *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 1.15 %
- 40-49: 1.72 %
- 50-59: 8.05 %
- 60+: 89.08 %
Conditions people have *:
You may use this to check any potential undetected conditions.
Other drugs people take *:
You may use this to check any potential interacting drugs.
Other side effects people have besides Chronic obstructive pulmonary disease *:
You may use this to check any potential undetected side effects.
* Approximation only. Some reports may have incomplete information.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Peng, C. C., Chen, C. Y., Chen, C. R., Chen, C. J., Shen, K. H., Chen, K. C., & Peng, R. Y., "Renal Damaging Effect Elicited by Bicalutamide Therapy Uncovered Multiple Action Mechanisms As Evidenced by the Cell Model", Scientific reports, 2018 Jan .
- Peng, C. C., Chen, C. Y., Chen, C. R., Chen, C. J., Shen, K. H., Chen, K. C., & Peng, R. Y., "Renal Damaging Effect Elicited by Bicalutamide Therapy Uncovered Multiple Action Mechanisms As Evidenced by the Cell Model", Scientific reports, 2018 Jan .
Related studies
Drugs with ingredients of bicalutamide, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on bicalutamide. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Vraylar and Acyclovir - now
- Myasthenia Gravis and Rheumatoid Arthritis - a second ago
- Polyneuropathy and drugs of ingredients of acetaminophen; butalbital; caffeine - 3 seconds ago
- Plaquenil and Fatigue Aggravated for Women aged 20-29 - 4 seconds ago
- Could Effexor Xr cause Laryngospasm? - 9 seconds ago
- Could Diabeta cause Nasal Congestion? - 21 seconds ago
- Drug interactions of Merrem and Ibu - 21 seconds ago
- Could Naproxen cause Steatorrhea? - 23 seconds ago
- Could Metoprolol Tartrate cause Foetal Growth Restriction? - 26 seconds ago
- Could Triatec cause Coronary Heart Disease? - 45 seconds ago